- Report
- March 2024
- 199 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- February 2024
- 250 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- April 2024
- 194 Pages
Global
From €4787EUR$4,950USD£4,103GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1209EUR$1,250USD£1,036GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1209EUR$1,250USD£1,036GBP
- Report
- March 2024
- 180 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 189 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 186 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 221 Pages
Global
From €2369EUR$2,450USD£2,031GBP
- Report
- January 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- August 2023
- 250 Pages
Global
From €2408EUR$2,490USD£2,064GBP
- Report
- April 2024
- 146 Pages
Global
From €5270EUR$5,450USD£4,517GBP
- Report
- April 2024
- 196 Pages
Global
From €4787EUR$4,950USD£4,103GBP
- Report
- November 2023
- 148 Pages
Global
From €2417EUR$2,499USD£2,071GBP
- Report
- September 2023
- 146 Pages
Global
From €2417EUR$2,499USD£2,071GBP
- Report
- April 2024
- 193 Pages
Global
From €4787EUR$4,950USD£4,103GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2901EUR$3,000USD£2,486GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2901EUR$3,000USD£2,486GBP
The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more